Mylan Suit Is a Witchhunt for Company's Internal Moles, Paper Claims
Mylan’s lawsuit against the Pittsburgh Post-Gazette is nothing but an extension of its internal witch-hunt for the identities of executives who have been leaking information to the paper, the P-G claims.
Mylan sued the P-G after it broke a devastating story that alleged safety violations at Mylan’s Morgantown, Pa., plant. The FDA later investigated and cleared the site for further business, but the FDA confirmed that software had been overridden by Mylan workers:
“No data was deleted, and the audit trails were intact for each instance where the software was overridden by the operator,” according to the agency’s statement.
The P-G argues in papers filed in response to the suit:
Mylan’s suit is aimed, not at meritless efforts of holding the Post-Gazette liable, but at attempting to uncover the Post-Gazette’s sources of information.
The back story: Mylan and the P-G have a long history of beefs, making this suit personal. The litigation will inevitably be of the entertaining “scorched-earth” variety.”
And finally: P-G claims its story was “meticulously accurate.”
- Previously:
- Mylan CFO Exits; Analyst Asks: “What Is Wrong Inside The Company?”
- Mylan Seeks Names of Moles; Internal Probe Failed to Find Them
- The Agenda Behind Mylan’s Suit v. the Pittsburgh Post-Gazette
- Did Mylan’s CEO Libel Pittsburgh Reporters Who Triggered FDA Probe?
- It’s Not Mylan’s First Quality Control Beef With FDA
Jim Edwards, a former managing editor of Adweek, has covered drug marketing at Brandweek for four years, and is a former Knight-Bagehot fellow at Columbia University's business and journalism schools. Follow him on Twitter or send him an email.





BNET User Analysis